Live feed08:30:00·178dPRReleaseCellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade GliomaCLRB· Cellectar Biosciences Inc.Health CareOriginal source
